SCHEMBL8804302

SCHEMBL8804302

C=C(Cl)COC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8078648 0.72
SCHEMBL5215895 0.72
SCHEMBL1058224 0.72
SCHEMBL1706297 0.69
SCHEMBL7365924 0.69
SCHEMBL4680225 0.69
SCHEMBL87087 0.69
SCHEMBL11148275 0.69
SCHEMBL27090352 0.69
SCHEMBL19412594 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478341-A High-adaptability amphoteric phosphate-based water reducer and preparation method thereof 广东苏博特新材料有限公司 2023-07-25 CN disclosed
US-20150031677-A1 TRIOXANE THIOACETAL MONOMERS AND DIMERS AND METHODS OF USE THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2015-01-29 US disclosed
WO-2014063167-A1 THIAZOLE-BASED INHIBITORS OF SCAVENGER RECEPTOR BI THE BROAD INSTITUTE, INC. (US) 2014-04-24 WO disclosed
EP-1911828-A1 Liquid crystal display Merck Patent GmbH (DE) 2008-04-16 EP disclosed
EP-0796259-A2 NOVEL PYRIMIDINYLOXY- AND PYRIMIDINYLAMINO-ETHYLPHENYL-DIOXOLANE DERIVATIVES Novartis AG (CH) 1997-09-24 EP disclosed
WO-1997009316-A1 4-[2-(PYRIMIDIN-4-OXY- OR 4-YLAMINO)-ETHYL]-PHENYL-OXIMES NOVARTIS AG (CH) 1997-03-13 WO disclosed
WO-1996017843-A2 NOVEL PYRIMIDINYLOXY- AND PYRIMIDINYLAMINO-ETHYLPHENYL-DIOXOLANE DERIVATIVES NOVARTIS AG (CH) 1996-06-13 WO disclosed